1 Min Read
May 2 (Reuters) - Drugmaker Pfizer Inc reported a 2.7 percent rise in quarterly profit, helped by higher sales of breast cancer drug Ibrance.
The largest U.S. drugmaker's net profit rose to $3.12 billion, or 51 cents per share, in the first quarter, from $3.04 billion, or 49 cents per share, a year earlier.
Revenue fell 1.7 percent to $12.78 billion. (Reporting by Divya Grover in Bengaluru; Editing by Saumyadeb Chakrabarty)